Lingkang Pharmaceutical announced that the company's wholly-owned subsidiary Lingkang Pharmaceutical products were selected for centralized volume procurement by an inter-provincial alliance of 34 drugs led by Henan Province. The procurement cycle is 2 years, and the participating provinces cover many provinces, regions and cities across the country. This selection is conducive to broadening the channels of public hospitals within the alliance and increasing product coverage and sales scale.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.